1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Sources
2.3. Research Design
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MARKET, BY TYPE
5.1. Introduction
5.2. Public Blockchain
5.3. Private Blockchain
5.4. Hybrid Blockchain
6. BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MARKET, BY APPLICATION
6.1. Introduction
6.2. Drug Traceability and Authentication
6.3. Supply Chain Transparency and Visibility
6.4. Counterfeit Drug Prevention
6.5. Inventory Management
6.6. Clinical Trials Management
6.7. Others
7. BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MARKET, BY END-USER
7.1. Introduction
7.2. Pharmaceutical Companies
7.3. Drug Distributors and Wholesalers
7.4. Pharmacies and Retailers
7.5. Healthcare Providers
7.6. Others
8. BLOCKCHAIN IN PHARMACEUTICAL SUPPLY CHAIN MARKET, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Taiwan
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. IBM Corporation
10.2. SAP SE
10.3. Chronicled Inc.
10.4. Ambrosus (Now part of Parity Technologies)
10.5. Chronicled, Inc.
10.6. MediLedger Project
10.7. FarmaTrust
10.8. Blockpharma
10.9. Chainvine
10.10. Genpact